Free Trial

Dr. Martens (DOCS) Competitors

Dr. Martens logo
GBX 73.55 +0.35 (+0.48%)
(As of 12/20/2024 12:01 PM ET)

DOCS vs. VTY, RMG, TEM, SPT, GEN, YOU, WIX, SST, CNIC, and API

Should you be buying Dr. Martens stock or one of its competitors? The main competitors of Dr. Martens include Vistry Group (VTY), Royal Mail (RMG), Templeton Emerging Markets Investment Trust (TEM), Spirent Communications (SPT), Genuit Group (GEN), YouGov (YOU), Wickes Group (WIX), Scottish Oriental Smaller Cos (SST), CentralNic Group (CNIC), and abrdn Property Income Trust (API). These companies are all part of the "computer software" industry.

Dr. Martens vs.

Vistry Group (LON:VTY) and Dr. Martens (LON:DOCS) are both consumer cyclical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, community ranking, media sentiment, analyst recommendations and institutional ownership.

Vistry Group has a beta of 2.14, meaning that its share price is 114% more volatile than the S&P 500. Comparatively, Dr. Martens has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500.

76.0% of Vistry Group shares are held by institutional investors. Comparatively, 69.5% of Dr. Martens shares are held by institutional investors. 0.6% of Vistry Group shares are held by company insiders. Comparatively, 4.4% of Dr. Martens shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Vistry Group received 39 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 91.67% of users gave Dr. Martens an outperform vote while only 56.82% of users gave Vistry Group an outperform vote.

CompanyUnderperformOutperform
Vistry GroupOutperform Votes
50
56.82%
Underperform Votes
38
43.18%
Dr. MartensOutperform Votes
11
91.67%
Underperform Votes
1
8.33%

Vistry Group has higher revenue and earnings than Dr. Martens. Vistry Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vistry Group£3.71B0.59£256.10M£0.73902.81
Dr. Martens£877.10M0.81£69.20M£0.071,050.71

Vistry Group presently has a consensus target price of GBX 860, indicating a potential upside of 30.49%. Given Vistry Group's stronger consensus rating and higher probable upside, analysts plainly believe Vistry Group is more favorable than Dr. Martens.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vistry Group
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Dr. Martens
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Dr. Martens has a net margin of 7.89% compared to Vistry Group's net margin of 6.90%. Dr. Martens' return on equity of 17.92% beat Vistry Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Vistry Group6.90% 7.80% 3.43%
Dr. Martens 7.89%17.92%8.12%

In the previous week, Vistry Group had 2 more articles in the media than Dr. Martens. MarketBeat recorded 3 mentions for Vistry Group and 1 mentions for Dr. Martens. Vistry Group's average media sentiment score of 1.48 beat Dr. Martens' score of 1.18 indicating that Vistry Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vistry Group
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Dr. Martens
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Vistry Group pays an annual dividend of GBX 55 per share and has a dividend yield of 8.3%. Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 4.1%. Vistry Group pays out 7,534.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Dr. Martens pays out 4,285.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

Vistry Group beats Dr. Martens on 11 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DOCS vs. The Competition

MetricDr. MartensFootwear & Accessories IndustryCyclical SectorLON Exchange
Market Cap£707.35M£12.45B£2.69B£1.58B
Dividend Yield4.63%1.99%4.15%11.58%
P/E Ratio1,050.71107.97341.051,561.57
Price / Sales0.8132.25323.48321,241.47
Price / Cash14.2920.2826.5136.80
Price / Book1.944.183.192.82
Net Income£69.20M£169.65M£273.85M£166.53M
7 Day Performance-3.92%-0.45%-1.47%-1.71%
1 Month Performance35.95%8.44%0.05%14.78%
1 Year Performance-18.23%6.47%8.43%24.82%

Dr. Martens Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DOCS
Dr. Martens
N/AGBX 73.55
+0.5%
N/A-18.3%£707.35M£877.10M1,050.71890Positive News
Gap Down
VTY
Vistry Group
3.0537 of 5 stars
GBX 656
-0.7%
GBX 860
+31.1%
-25.8%£2.19B£3.71B898.634,400
RMG
Royal Mail
N/AN/AN/AN/A£1.98B£12.71B339.34100News Coverage
TEM
Templeton Emerging Markets Investment Trust
N/AGBX 168.60
-0.8%
N/A+10.1%£1.80B£173.08M1,416.67N/A
SPT
Spirent Communications
2.6176 of 5 stars
GBX 177.20
-0.9%
GBX 246.25
+39.0%
+47.1%£1.01B£447.70M8,880.001,526News Coverage
GEN
Genuit Group
2.8849 of 5 stars
GBX 399.50
-0.4%
GBX 512.50
+28.3%
-2.8%£995.43M£554.10M4,010.002,700Insider Trade
News Coverage
Gap Down
YOU
YouGov
2.4581 of 5 stars
GBX 449.46
+0.8%
GBX 905
+101.4%
-64.9%£524.83M£270M2,241.761,820Gap Up
WIX
Wickes Group
2.1525 of 5 stars
GBX 153
-1.0%
GBX 180
+17.6%
+5.4%£362.75M£1.53B1,288.335,930Gap Down
SST
Scottish Oriental Smaller Cos
N/AGBX 1,500
+1.0%
N/A+18.4%£353.25M£53.86M889.22320
CNIC
CentralNic Group
N/AN/AN/A+0.0%£339.82M£790.04M-12,660.00100
API
abrdn Property Income Trust
N/AGBX 60.80
+0.5%
N/A-87.4%£231.78M£32.44M-3,025.001,310Ex-Dividend
News Coverage
Positive News

Related Companies and Tools


This page (LON:DOCS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners